$41.2M
800k
0.75%
$54.4
Seth Klarman acquired 800k Vaxcyte shares worth $41.2M. That's 0.75% of their equity portfolio (20th largest holding). The investor's estimated purchase price is $43.5M, resulting in a loss of 5.5%.
Easily embed the chart on your blog or website – it will always update automatically!
To improve your user experience we use cookies. Privacy Policy
Necessary for the website to function.
Help us understand how you use our site.
Used to show relevant ads.